Search research articles
Contact Us
Filters
Showing results (101-110 of 651) with videos related to
Page
of 66
Sort By:
Cancer Chemotherapy and Biological Response Modifiers
|
January 1, 1987
Breast cancer
C L Loprinzi, P P Carbone
American Journal of Obstetrics and Gynecology
|
November 1, 1993
Genital and nongenital teratogenesis of prenatal progestogen therapy: the effects of 17 alpha-hydroxyprogesterone caproate on embryonic and fetal development and endochondral ossification in the C57B1/6J mouse
J P Carbone, R L Brent
Translational Lung Cancer Research
|
December 9, 2017
Blood-based biomarkers in lung cancer: prognosis and treatment decisions
Meng Xu-Welliver, David P Carbone
Minerva Urologica
|
April 1, 1978
[Hypertension caused by arteriovenous fistula in a patient with renal neoplasms]
P Carbone, G Piancino, N Rizzello
Minerva Urologica
|
April 1, 1982
[Diagnostic difficulties in non-neoplastic renal masses]
T Cammarota, P Carbone, R Fiore
American Journal of Respiratory and Critical Care Medicine
|
June 11, 2003
From clinical and pathologic to molecular staging of lung cancer
Pierre P Massion, David P Carbone
Immunologic Research
|
July 11, 2001
VEGF as a mediator of tumor-associated immunodeficiency
J E Ohm, D P Carbone
Advances in Internal Medicine
|
January 1, 1992
The molecular genetics of lung cancer
D P Carbone, J D Minna
Cancer Chemotherapy and Biological Response Modifiers
|
January 1, 1994
Breast cancer
P P Carbone, H H Bailey
Journal of Thoracic Disease
|
May 20, 2017
Non-small cell lung cancer genomics around the globe: focus on ethnicity
Luiz H Araujo, David P Carbone
Page
of 66
Search research articles
Search
Showing results (101-110 of 651) with videos related to
Sort By:
Page
of 66
Cancer Chemotherapy and Biological Response Modifiers
|
January 1, 1987
Breast cancer
C L Loprinzi, P P Carbone
American Journal of Obstetrics and Gynecology
|
November 1, 1993
Genital and nongenital teratogenesis of prenatal progestogen therapy: the effects of 17 alpha-hydroxyprogesterone caproate on embryonic and fetal development and endochondral ossification in the C57B1/6J mouse
J P Carbone, R L Brent
Translational Lung Cancer Research
|
December 9, 2017
Blood-based biomarkers in lung cancer: prognosis and treatment decisions
Meng Xu-Welliver, David P Carbone
Minerva Urologica
|
April 1, 1978
[Hypertension caused by arteriovenous fistula in a patient with renal neoplasms]
P Carbone, G Piancino, N Rizzello
Minerva Urologica
|
April 1, 1982
[Diagnostic difficulties in non-neoplastic renal masses]
T Cammarota, P Carbone, R Fiore
American Journal of Respiratory and Critical Care Medicine
|
June 11, 2003
From clinical and pathologic to molecular staging of lung cancer
Pierre P Massion, David P Carbone
Immunologic Research
|
July 11, 2001
VEGF as a mediator of tumor-associated immunodeficiency
J E Ohm, D P Carbone
Advances in Internal Medicine
|
January 1, 1992
The molecular genetics of lung cancer
D P Carbone, J D Minna
Cancer Chemotherapy and Biological Response Modifiers
|
January 1, 1994
Breast cancer
P P Carbone, H H Bailey
Journal of Thoracic Disease
|
May 20, 2017
Non-small cell lung cancer genomics around the globe: focus on ethnicity
Luiz H Araujo, David P Carbone
Page
of 66